Tag: Pfizer

Pfizer CEO: Fourth COVID-19 Vaccine Dose Necessary

The CEO of Pfizer said Sunday that a fourth dose of the COVID-19 vaccine will be necessary, claiming that it will continue to reduce hospitalizations. “Clearly we are not where we would all like to be, which is [where] COVID is behind us,” CEO Albert Bourla told CBS News. “I think that right now we have…


More Data Finds Pfizer Vaccine Less Protective in Children 5 to 15 Years With Omicron

New data suggests that two doses of the Pfizer COVID-19 vaccine do not provide very much protection from infection for children 5 to 15 years against the Omicron variant of the CCP virus, according to new data published in the Center for Disease Control and Prevention (CDC) journal, Morbidity and Mortality Weekly Report. The CDC…


More Data Finds Pfizer Vaccine Less Protective in Children 5 to 15 With Omicron

New data suggests that two doses of the Pfizer COVID-19 vaccine don’t provide very much protection from infection for children 5 to 15 years old against the Omicron variant of the CCP virus, according to new data published by the Centers for Disease Control and Prevention (CDC) journal Morbidity and Mortality Weekly Report. The CDC…


Facts Matter (March 11): The Pfizer Documents: 158K Adverse Events, 42K Case reports, 1.2K Fatalities in First 3 Months

Just a few days ago, the FDA finally released its first batch of 10,000 documents related to its authorization of the Pfizer vaccine. And within these documents, there is a breakdown of not only the number of fatalities but also the number of adverse reactions that people experience during the first three months of the…


Pfizer to Ask US Regulators to Authorize Second Booster Due to Waning Effectiveness: CEO

Pfizer plans to ask U.S. regulators to grant emergency use authorization for a second booster of its COVID-19 vaccine, CEO Albert Bourla said March 11. “Clearly there is a need in an environment of Omicron to boost the immune response,” Bourla said on CNBC’s “Squawk Box.” Pfizer’s vaccine waned over time in protection against both…


Pfizer Begins Study of COVID-19 Pill in High-Risk Children

Pfizer has started a study of its COVID-19 pill in children who have COVID-19 and are designated as high-risk for experiencing severe symptoms. The phase 2/phase 3 study has approximately 140 participants between the ages of 6 and 17. One cohort will receive Pfizer’s pill, known as Paxlovid or nirmatrelvir, twice a day for five…


COVID-19 Vaccine Risks May Outweigh Benefits for Healthy Children: New Florida Guidance

New guidance from Florida’s top health official says parents should know healthy children might be more at risk from a COVID-19 vaccine than from COVID-19 itself. The guidance (pdf), issued a day after it was announced, notes that children without comorbidities are at little risk of developing severe COVID-19 and that youth are at heightened…


Trio of New Studies Revives Question: Should Children Get a COVID-19 Vaccine?

Three newly published studies have revived concerns about COVID-19 vaccines for young children, many of whom are at little risk of contracting serious cases of the illness. Youth under 18 are the least likely age group to need hospital care after getting COVID-19 but Pfizer’s COVID-19 vaccine was authorized in 2020 for those 16 and…


Ontario Judge Rules in Favour of Mother Who Doesn’t Want Her Children to Receive COVID Vaccine

An Ontario judge has ruled in favour of a mother who does not want her two children to be vaccinated against COVID-19, contrary to what her ex-husband wants, noting in his ruling that government pandemic policies have changed over time. In his ruling, the first of its kind among pandemic-related litigation in Canada, Ontario Superior Court…


Ontario Judge Rules in Favour of Mother Who Doesn’t Want Her Children Vaccinated for COVID

An Ontario judge has ruled in favour of a mother who does not want her two children to be vaccinated against COVID-19, contrary to what her ex-husband wants, noting in his ruling that government pandemic policies have changed over time. In his ruling, the first of its kind regarding pandemic-related litigation in Canada, Ontario Superior Court…